Related Experiment Video
Updated: Aug 12, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Bacteremia in patients with cystic fibrosis
Insights
Bacteremia, or bloodstream infection, is reported for the first time in cystic fibrosis (CF) patients. This finding challenges the assumption of robust immunity in CF, highlighting the need for further investigation into CF bacteremia.
Area of Science:
- Medical Microbiology
- Pediatric Pulmonology
- Immunology
Background:
- Bacteremia is uncommon in cystic fibrosis (CF) patients, likely due to heightened systemic immunity associated with chronic lung infections.
- Previous literature has not documented instances of bacteremia in individuals with CF.
Purpose of the Study:
- To report the occurrence of bacteremia in pediatric patients diagnosed with cystic fibrosis.
- To investigate the causative organisms and potential sources of bacteremia in CF patients.
Main Methods:
- Case series reporting on three patients with cystic fibrosis and documented bacteremia.
- Identification of bacterial pathogens from blood cultures and autopsy samples.
- Assessment of patients' immune status through clinical history and laboratory data.
Main Results:
- Two infants and one adolescent with CF presented with documented or premortem bacteremia.
- Identified pathogens included Staphylococcus aureus, Serratia marcescens, and Pseudomonas aeruginosa, presumed to originate from the respiratory tract.
- No evidence of primary immunodeficiency was found in the affected patients.
Conclusions:
- This study presents the first documented cases of bacteremia in cystic fibrosis patients.
- The findings suggest that bacteremia can occur in CF despite presumed immune activation.
- Further research is required to determine the incidence and specific circumstances of bacteremia in CF.
Abstract:
Bacteremia in patients with cystic fibrosis (CF) has not been previously reported, a fact probably attributable to activated systemic immunity in the presence of chronic bronchopulmonary infection. We have observed two CF patients under a year of age with documented bacteremia, and a teen-aged patient with autopsy evidence of premortem bacteremia. Organisms were Staphylococcus aureus, Serratia marcescens, and Pseudomonas aeruginosa, having presumably spread from the lower respiratory tract in both patients. None of the patients had historical or laboratory evidence of immunodeficiency. The true incidence of bacteremia in CF patients is unknown, and the circumstances under which it occurs have not yet been defined.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Urinary Tract Infection II: Pathophysiology
Microbiota of the Respiratory Tract
Bacterial Meningitis
Cryptococcal Meningitis
Pneumonia I: Introduction

